Melatonin Use in Patients With Climacterious Symptoms in the Perimenopause
NCT06192641
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
24
Enrollment
OTHER
Sponsor class
Conditions
Perimenopausal Disorder
Interventions
DRUG:
Melatonin 3 MG
Sponsor
Univates
Collaborators
[object Object]
[object Object]